1 year return (CAGR)
-99.92%
Lipella Pharmaceuticals Inc. Common Stock Exchange (NASDAQ, USD)
LIPO
0.00
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-96.88%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
2.31K
Price/Sales
0.00
Ent value
-991.25K
Price/Book
0.00
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.00 |
| Daily high | 0.00 |
| Daily low | 0.00 |
| Daily Volume | 0K |
| All-time high | 37.68 |
| 1y analyst estimate | 10.00 |
| Beta | 1.57 |
| EPS (TTM) | -276.57 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 25 Feb 2026 |
Downside potential
Loading...
Downside potential data
| LIPO | S&P500 | |
| Current price drop from All-time high | -100.00% | -0.58% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 14 Aug 2026 | 9 Mar 2009 |
| Avg drop from high | -83.93% | -10.68% |
| Avg time to new high | 472 days | 12 days |
| Max time to new high | 942 days | 1805 days |
News
